June 17, 2024 5:29 pm ET RAHWAY, N.J.–(BUSINESS WIRE)– Merck (NYSE: MRK), known as MSD outside of the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) … [+14569 chars]Read More
US FDA Approves CAPVAXIVE Pneumococcal 21valent Conjugate Vaccine for Prevention of Invasive Pneumococcal Disease and Pneumococcal Pneumonia in Adults Merck
